Raloxifene and cut in breast cancer risk
A drug used to treat thinning bones in older women has also been found to significantly reduce the risk of breast cancer according to a four year American study.
The drug, Raloxifene, reduced the risk of invasive breast cancer by 72% and the researchers have also calculated that it reduced the risk of oestrogen dependent breast cancer by 84%. A new study of 22,000 women is now due to start which will compare the effects of raloxifene on the development of breast cancer with tamoxifen.
(23rd Annual San Antonio Breast Cancer Symp.)